Cargando…
Could Intravenous Immunoglobulin Collected from Recovered Coronavirus Patients Protect against COVID-19 and Strengthen the Immune System of New Patients?
The emergence of the novel coronavirus in Wuhan, China, which causes severe respiratory tract infections in humans (COVID-19), has become a global health concern. Most coronaviruses infect animals but can evolve into strains that cross the species barrier and infect humans. At the present, there is...
Autor principal: | Jawhara, Samir |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7178250/ https://www.ncbi.nlm.nih.gov/pubmed/32218340 http://dx.doi.org/10.3390/ijms21072272 |
Ejemplares similares
-
Intravenous immunoglobulin immunotherapy for coronavirus disease‐19 (COVID‐19)
por: Galeotti, Caroline, et al.
Publicado: (2020) -
Can Drinking Microfiltered Raw Immune Milk From Cows Immunized Against SARS-CoV-2 Provide Short-Term Protection Against COVID-19?
por: Jawhara, Samir
Publicado: (2020) -
The original sins of clinical trials with intravenous immunoglobulins in sepsis
por: Almansa, Raquel, et al.
Publicado: (2015) -
How to boost the immune defence prior to respiratory virus infections with the special focus on coronavirus infections
por: Jawhara, Samir
Publicado: (2020) -
Severe Coronavirus Disease 2019 That Recovered from Respiratory Failure by Treatment That Included High-dose Intravenous Immunoglobulin
por: Suzuki, Yasuhito, et al.
Publicado: (2020)